The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high‐grade transformation
Samuel Backman(Uppsala University), Joakim Crona(Uppsala University), Anders Sundin, Kazhan Mollazadegan(Uppsala University), Jonas Carlsson Almlöf(Uppsala University), Per Hellman(Uppsala University Hospital), C. Christofer Juhlin(Karolinska University Hospital), Helena Nord(Uppsala University), Karel Pacák(Endocrine Society), Britt Skogseid(Uppsala University), Johan Botling(Uppsala University Hospital), Liang Zhang(Uppsala University), Peter Stålberg(Uppsala University Hospital), Staffan Welin(Uppsala University), Lotte Moens(Uppsala University), Barbro Eriksson, Tobias Åkerström(Uppsala University), Suman Ghosal(National Institute of Allergy and Infectious Diseases)
Cited by 15
Related Papers
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
|The Journal of Clinical Endocrinology & Metabolism|2005|711